COVID-19 and Genitourinary Cancers
Delivering exercise medicine to cancer survivors: has COVID-19 shifted the landscape for how and who can be reached with supervised group exercise?
November 9, 2021
Continued Androgen Signalling Inhibition improves Cabazitaxel Efficacy in Prostate Cancer.
November 9, 2021
Unemployment and cancer screening: Baseline estimates to inform health care delivery in the context of COVID-19 economic distress.
November 9, 2021
The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic.
October 18, 2021
Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patients.
October 13, 2021
Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic.
October 8, 2021
Twitter as a Tool to Spread Communication Regarding Genitourinary Cancers During the COVID-19 Pandemic.
August 11, 2021
Leveraging Social Media as a Thermometer to Gauge Patient and Caregiver Concerns: COVID-19 and Prostate Cancer.
August 10, 2021
How to manage patients with suspected upper tract urothelial carcinoma in the pandemic of COVID-19?
August 5, 2021